CandlesenseCandlesense
News/Companies/ARAY

ARAY News

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

ARAY

Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025. Key Fiscal Fourth Quarter...

August 13, 2025Earnings
Read more →

12 Health Care Stocks Moving In Friday's Intraday Session

ARAY

June 6, 2025
Read more →

Accuray To Exchange $82M Of 3.75% Convertible Notes For 8.88M Shares And $68.6M Cash In Debt Reduction Deal Closing June 11

ARAY

June 6, 2025
Read more →

Accuray Announces That New Data Presented At The European Society For Radiotherapy And Oncology Meeting Reinforces The Benefits Of The Company's CyberKnife System In The Treatment Of Prostate Cancer At Multiple Stages Of The Cancer Journey

ARAY

May 7, 2025
Read more →

Accuray Reports First SRS/SBRT Patient Treatments in Austria With the CyberKnife System

ARAY

May 5, 2025
Read more →

Accuray Lowers FY2025 Sales Guidance from $463.00M-$475.00M to $452.00M-$460.00M vs $468.30M Est

ARAY

April 30, 2025
Read more →

Accuray Q3 EPS $(0.01) Beats $(0.05) Estimate, Sales $113.24M Beat $101.53M Estimate

ARAY

April 30, 2025
Read more →

Accuray Announced That New Data On The Clinical Use Of The CyberKnife System Reinforce The Device's Broad-based Radiation Treatment Capabilities For Central Nervous System Tumors

ARAY

April 3, 2025
Read more →

Accuray's Radixact SynC System And CyberKnife S7 System Have Been Approved By The Chinese National Medical Products Administration

ARAY

January 13, 2025
Read more →

Accuray Q1 2025 GAAP EPS $(0.04) Beats $(0.05) Estimate, Sales $101.500M Beat $97.552M Estimate

ARAY

November 6, 2024
Read more →